Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, is conditionally authorized by the European Commission for the treatment of certain hematological malignancies FarmaMondo has been granted distribution rights for Zemcelpro® in Argentina, Hong Kong and Singapore MONTREAL, July...
View original →